Pharming (PHAR) Receivables (2019 - 2026)
Pharming's Receivables came in at $56.98 million for Q2 2026, up 6.9% from $53.33 million a year earlier but down 5.1% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming's Receivables was $54.7 million, down 0.2% from FY2024.
- Receivables carries a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
- Going back by year, Receivables was $54.82 million in FY2024 (+18.8%), $46.16 million in FY2023 (+67.1%), $27.62 million in FY2022 and $30,263 in FY2021 (-99.9%).
- The five-year range for quarterly Receivables is $28,828 (Q3 2022) to $60.03 million (Q1 2026).
- Year-over-year, Receivables increased in six of the last eight quarters, with growth averaging 11.0%.
- The fastest year-over-year change in Receivables over five years came in Q4 2023 (growth of 67.1%), and the weakest in Q4 2021 (a decline of 99.9%).
- Business Quant data shows PHAR's Receivables at $60.03 million (Q1 2026), $54.7 million (Q4 2025) and $43.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn | 56.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.98 Mn |
| Mar 31, 2026 | 60.03 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 43.61 Mn |
| Jun 30, 2025 | 53.33 Mn |
| Mar 31, 2025 | 47.49 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Sep 30, 2024 | 48.20 Mn |
| Jun 30, 2024 | 51.12 Mn |
| Mar 31, 2024 | 38.70 Mn |
| Dec 31, 2023 | 46.16 Mn |
| Sep 30, 2023 | 40.52 Mn |
| Jun 30, 2023 | 33.16 Mn |
| Mar 31, 2023 | 32.93 Mn |
| Dec 31, 2022 | 27.62 Mn |
| Sep 30, 2022 | 28,828.00 |
| Jun 30, 2022 | 32.88 Mn |
| Mar 31, 2022 | 31.45 Mn |
| Dec 31, 2021 | 29.98 Mn |
| Sep 30, 2021 | 32.81 Mn |
API Access
Pharming Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();